James O'Brien

James O'Brien

Directeur Financier/CFO chez MESOBLAST LIMITED
59 ans
Health Technology
Commercial Services
Consumer Services

Profil

James M.
O'Brien
is currently Chief Financial Officer at Mesoblast Ltd. since 2025.
Former positions include Chief Financial Officer at Faron Pharmaceuticals Oy from 2023 to 2024, Chief Financial Officer at Cognition Therapeutics, Inc. from 2019 to 2022, Executive Vice President-Finance at Enzo Biochem, Inc. from 2014 to 2019, Vice President & Corporate Controller at Allergan UC from 2010 to 2013, Vice President at Takeda Pharmaceutical Co., Ltd. in 2010, Chief Accounting Officer at U.S.I.
Holdings Corp.
from 2008 to 2009, Vice President & Controller at Aptuit LLC from 2005 to 2007, Chief Accountant at Purdue Pharma LP, and Principal at both Bristol Myers Squibb Co. and PricewaterhouseCoopers LLP.
Education includes undergraduate studies at George Washington University and an MBA from Fordham University.

Postes actifs de James O'Brien

SociétésPosteDébut
MESOBLAST LIMITED Directeur Financier/CFO 17/11/2025

Anciens postes connus de James O'Brien

SociétésPosteFin
FARON PHARMACEUTICALS OY Directeur Financier/CFO 15/04/2024
COGNITION THERAPEUTICS, INC. Directeur Financier/CFO 12/08/2022
ENZO BIOCHEM, INC. Corporate Officer/Principal 03/11/2019
ALLERGAN PLC Comptroller/Controller/Auditor -
TAKEDA PHARMACEUTICAL COMPANY LIMITED Corporate Officer/Principal 01/08/2010
Voir l'expérience en détail de James O'Brien

Formation de James O'Brien

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

28

Relations au 1er degré

13

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées13

Health Technology

Health Technology

Commercial Services

Finance

Commercial Services

Health Technology

Consumer Services

Distribution Services

Consumer Services

Health Technology

Health Technology

Health Technology

Health Technology

  1. Bourse
  2. Insiders
  3. James O'Brien
DERNIÈRES HEURES | -40% : Les Meilleurs Outils Réservés aux Abonnés pour Identifier les Meilleurs Investissements de Demain !
j
:
:
PROFITEZ-EN MAINTENANT
🔇